Literature DB >> 7719706

Molecular characterization and chromosome localization of a human angiotensin II AT2 receptor gene highly expressed in fetal tissues.

D Lazard1, M M Briend-Sutren, P Villageois, M G Mattei, A D Strosberg, C Nahmias.   

Abstract

The gene encoding the human angiotensin II (AT2) receptor exists as a single copy and contains no intron in its coding region. Its nucleotide sequence is identical to that of cDNA clones isolated from human myometrial library. In addition, binding properties of the corresponding receptor expressed in COS cells are identical to those of endogenous AT2 receptors from human myometrium. The human AT2 receptor gene translates into a polypeptide of 363 amino-acid residues that belongs to the seven transmembrane domains receptor superfamily. This polypeptide shows 92% amino-acid sequence homology and the same pharmacological profile as AT2 receptors recently isolated from rat and mouse. The AT2 receptor gene maps to the X chromosome in man (region Xq24-q25) as well as in mouse (region XA2-A4). These findings open new perspectives regarding a potential involvement of AT2 receptors in X-linked congenital diseases. Expression of AT2 receptor mRNA is found in human myometrium, fallopian tubes and adrenals, and at extremely high levels in fetal kidney and intestine. These results indicate that AT2 receptor gene expression is regulated during human embryonic development, and support the hypothesis that AT2 receptors may play a role in organogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7719706

Source DB:  PubMed          Journal:  Receptors Channels        ISSN: 1060-6823


  15 in total

1.  Restriction of placental and fetal growth in sheep alters fetal blood pressure responses to angiotensin II and captopril.

Authors:  L J Edwards; G Simonetta; J A Owens; J S Robinson; I C McMillen
Journal:  J Physiol       Date:  1999-03-15       Impact factor: 5.182

Review 2.  Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease?

Authors:  Philip Rosenstiel; Stefan Gallinat; Alexander Arlt; Thomas Unger; Jobst Sievers; Ralph Lucius
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 3.  Novel actions of angiotensin II via its renal type-2 (AT(2)) receptor.

Authors:  R M Carey; Z Q Wang; H M Siragy
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

4.  Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements.

Authors:  C Warnecke; T Willich; J Holzmeister; S P Bottari; E Fleck; V Regitz-Zagrosek
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 5.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

6.  Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells.

Authors:  Lara Pickel; Takaya Matsuzuka; Chiyo Doi; Rie Ayuzawa; Dharmendra Kumar Maurya; Sheng-Xue Xie; Cory Berkland; Masaaki Tamura
Journal:  Cancer Biol Ther       Date:  2009-12-22       Impact factor: 4.742

7.  Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase.

Authors:  K Bedecs; N Elbaz; M Sutren; M Masson; C Susini; A D Strosberg; C Nahmias
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

Review 8.  Mechanism of action of angiotensin-receptor blocking agents.

Authors:  H M Siragy; M Bedigian
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

Review 9.  The angiotensin II type 2 receptor and the kidney.

Authors:  Helmy M Siragy
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2009-10-27       Impact factor: 1.636

10.  Contractility of placental vascular smooth muscle cells in response to stimuli produced by the placenta: roles of ACE vs. non-ACE and AT1 vs. AT2 in placental vessel cells.

Authors:  C Benoit; Y Gu; Y Zhang; J S Alexander; Y Wang
Journal:  Placenta       Date:  2008-04-15       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.